The largest database of trusted experimental protocols

7 protocols using recombinant g csf

1

Neutrophil Differentiation from Murine Bone Marrow

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were sterilely harvested from tibiae and femurs of C3H/HeJ mice (stock#000659, The Jackson laboratory, Bar Harbor, Maine; Resistance to lipopolysaccharide or LPS due to a spontaneous mutation in toll-like receptor 4 or tlr4 gene). After lysing red blood cells, bone marrow cells were cultured at the cell density of 2 × 106/ml in RPMI 1640medium in 10cm dish (BD Biosciences, Durham, NC) at 37 °C, 5% CO2, supplemented with 10% fetal calf serum (FCS, cat# 100-106, Gemini Bio-Products, West Sacramento, CA), 2 mM L-glutamine (cat#G7513, Sigma, St. Louis, MO), 1X MEM non-essential amino acids (cat# 11140-050, Gibco, Grand island, NY), 1mM sodium pyruvate (cat#25-000-CI, Cellgro, Manassas, VA), 0.5mM beta-mercaptoethanol (cat#M3148, Sigma),100U/ml penicillin G, 100μg/ml streptomycin (cat#30-002-CI, Cellgro). For making neutrophils, the bone marrow cells were cultured in the growth medium that contains 100ng/ml recombinant G-CSF (cat# 250-05, PeproTech) alone. Every 3 days, the floating cells were harvested and re-cultured in fresh growth medium. On day 8, cells floating in the supernatants were subjected to flow cytometry analysis for Ly-6G or Gr1 positivity. When the positivity reached >80%, the cells were used as neutrophils in individual experiments.
+ Open protocol
+ Expand
2

Immunomodulation of Tumor Microenvironment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were subcutaneously injected with 2 μg recombinant GCSF (PeproTech) in 100 μl PBS every day for 10 days. Mice bearing 1.0 cm diameter PyMT-B6 tumors were treated with 30 μg Flt3L (Celldex) daily for 9 days by intraperitoneal injection. Mice bearing 1.0 cm diameter PyMT-B6 tumors were treated with 50 μg anti-GCSF IgGs (clone 67604, R&D Systems), 500 μg anti-IL-6 IgGs (clone MP5-20F3, BioXCell), or matched isotype control three times per week by intraperitoneal injection for 2 weeks. Mice were treated with anti-Ly6G IgGs (clone 1A8, BioXCell) or matched isotype control, first dose 400 μg, 100 μg for subsequent doses, three times per week beginning at time point indicated in the experiment. Mice were treated with 200 μg anti-PD1 IgGs (clone RMP1-14, BioXCell) every 3 days by intraperitoneal injection. Mice were treated with 50 μg poly I:C every 5 days by intratumoral injection, according to time points indicated in the experiment.
+ Open protocol
+ Expand
3

Hematopoietic Progenitor Cell Isolation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse. Hematopoietic progenitor cells (HPCs) were isolated from mouse bone marrow by using a Lineage depletion kit (Miltenyi), according to the manufacturer’s instructions. Cells were seeded at 25,000 cell/ml in 24-well plates and recombinant GM-CSF (20 ng/ml; Invitrogen), 20% v/v TES were added on day 1 and day 3. At day 5, Ly6G positive neutrophils were isolated by using anti-Ly6G biotin (Miltenyi) and streptavidin beads (Miltenyi), according to manufacturer’s followed by suppression assay. In addition, total cells were stained and analyzed for flow cytometry. In other experiments, LY2228820 p38 inhibitor (1 μM; Selleckchem) was added to HPC culture on day 3.
Human. Hematopoietic progenitor cells (HPCs) were isolated from cord blood using the CD34 MicroBead Kit (Miltenyi), according to the manufacturer’s instructions. Cells were seeded at 5 × 104 cell/ml in 6-well plates with recombinant G-CSF (100 ng/ml; PeproTech) and GM-CSF (10 ng/ml; PeproTech). At day 7, 30% v/v TES were added and the next day flow cytometry analysis was performed.
+ Open protocol
+ Expand
4

Intranasal IL-33 and G-CSF modulate airway inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were intranasally administered 1 μg recombinant IL-33 protein (ThermoFisher Scientific) in 50μl PBS three times over a period of 1 week. In some experiments, mice were concomitantly intranasally administered 100 ng recombinant G-CSF (Peprotech, New Jersey, USA) in 50μl PBS (or PBS vehicle control) on a daily basis. When necessary, IL-33 was admixed with G-CSF for treatment of mice. Harvests were performed 24 hours post the final dose of IL-33.
In other experiments, mice administered HDM (i.n.) for 1 week (as detailed above) were also treated daily with 2.5 μg of recombinant G-CSF i.p. in 200μl PBS (or PBS vehicle control) and 100 ng G-CSF i.n. in 50μl PBS (or PBS vehicle control). Harvests were performed 24 hours post the final dose of G-CSF/HDM.
+ Open protocol
+ Expand
5

Isolation and differentiation of BM progenitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM cells were isolated, lineage depleted, and stained as described above. CD45.2+ MPs (Lin-cKit+ScaI), MDPs, or CDPs were isolated from whole BM of tumor-bearing or tumor-free mice by cell sorting on the ARIAII system (BD). A total of 2500 sorted progenitors were plated on 1.125 × 106 CD45.1+ BM cell feeder culture in RPMI-1640 medium (Lonza) supplemented with 10% fetal bovine serum (Atlanta Biological), β-mercaptoethanol (Gibco), non-essential amino acids (Life Technologies), and l-glutamine (Life Technologies) in the presence of 100 ng/ml recombinant Flt3L and/or 100 ng/ml recombinant GCSF (PeproTech) in 24-well plates. The medium was replaced after 3 days and cultures were analyzed after 5 days. To lift cells, 0.05% Trypsin (HyClone) was used. Cells were stained and analyzed as described for flow cytometry, identifying the progeny of isolated progenitors by CD45.2 positivity. For GCSF priming experiment, progenitors were treated with 100 ng/ml GCSF or media alone for 24 h prior to plating in differentiation assay described above.
+ Open protocol
+ Expand
6

Isolation and Differentiation of Murine Neutrophils

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were sterilely harvested from tibiae and femurs of C3H/HeJ mice. After lysing red blood cells, bone marrow cells were cultured at a cell density of 2×106 per ml in 10-cm dishes (BD Biosciences, Durham, NC, USA) at 37°C in an atmosphere of 5% CO2. Cells were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum (cat#100-106, Gemini Bio-Products, West Sacramento, CA, USA), 2 mM l-glutamine (cat#G7513, Sigma, St. Louis, MO, USA), 1X MEM non-essential amino acids (cat#11140-050, Gibco, Grand Island, NY, USA), 1 mM sodium pyruvate (cat#25-000-CI, Cellgro, Manassas, VA, USA), 0.5 mM beta-mercaptoethanol (cat#M3148, Sigma), 100 U/ml penicillin G, and 100 μg/ml streptomycin (cat#30-002-CI, Cellgro).
To make neutrophils, bone marrow cells were cultured in growth medium containing 100 ng/ml recombinant G-CSF (cat#250-05, PeproTech). Every 3 days, floating cells were harvested and re-cultured in fresh growth medium. On day 8, cells floating in the supernatants were analyzed by flow cytometry for the presence of Ly-6G or Gr1. When positivity was >80%, the cells were used as neutrophils in chemotaxis assays.
+ Open protocol
+ Expand
7

Neutrophil Transfection and Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenic neutrophils were sorted by the Anti-Ly-6G MicroBeads UltraPure kit (Catalog# 130-120-337, Miltenyi Biotec). Transient transfection of neutrophils was done as previously described.80 (link) In brief, three million neutrophils were electroporated with 300 nM of SMARTpool ON-TARGETplus siRNA which combines four gene-specific siRNAs into a single reagent pool using the P3 Primary Cell 4D-Nucleofector X Kit (Lonza, Switzerland) under human monocyte nucleofection program with an Amaxa electroporation system. The cells were then cultured for 48 h in the medium supplied with the kit containing 10% FBS and 30 ng/mL recombinant G-CSF (PeproTech, Rocky Hill, NJ).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!